News & Updates

Higher body mass index (BMI) may increase the risk of developing site-specific cancers in young men, reveals a recent study.

The number of risk factors compiled by the American Gastroenterological Association (AGA) is significantly associated with the risk of disease complications in Crohn’s disease (CD), but not in ulcerative colitis (UC), reports a study. The presence of three or more risk factors in CD contributes to the highest risk of complications.

As Professor Francis Chan reflected on his 11-year service as Dean of the Faculty of Medicine, the Chinese University of Hong Kong (CUHK), he shared his vision on the future of healthcare development in Hong Kong and how the city has the potential to become a hub for medical innovation and technology (I&T).

In the first-line treatment of patients with microsatellite instability-high or mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (CRC), dual immunotherapy using a combination of nivolumab and ipilimumab delivers a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared with chemotherapy, according to the CheckMate 8HW trial presented at ASCO GI 2024.

In patients who have had a first attack of pericarditis with evidence of myocardial involvement, treatment with colchicine is safe and helps reduce the risk of recurrence, according to a study.

Among Asian patients with systemic lupus erythematosus (SLE), those who are younger, male, from ethnic minority backgrounds, and have suboptimal disease control at time of vaccination are at increased risk of flares following mRNA COVID-19 vaccination.

Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist, results in some serious adverse events (AEs), including orthostatic hypotension and pseudohallucinations in healthy male volunteers, results of a study have shown.